Matinas Biopharma Holdings IMTNB
13F holders, Q2 2025 (June 30)24holders −1
3new positions
3sold out
1famous investor
$0.92avg. 13F price*
At the end of Q2 2025, 24 institutions reported holding Matinas Biopharma Holdings I (MTNB) in their 13F filings, down 1 from Q1 2025. 3 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($53K), Geode Capital Management, LLC ($49K) and BlackRock, Inc. ($44K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Matinas Biopharma Holdings I
- CUSIP
- 576810303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $342 |
| Exits | 3 | $25K |
All 13F filers, Q1 2025 → Q2 2025: 11,442 shares bought and 55,207 shares sold, net −43,765 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Vanguard Group Inc. | 0.00% | No change | 59,725 | $53K |
| Geode Capital Management, LLC | 0.00% | Add +18.7% | 55,494 | $49K |
| BlackRock, Inc. | 0.00% | No change | 49,650 | $44K |
| Holos Integrated Wealth LLC | 0.02% | No change | 32,480 | $37K |
| Sargent Investment Group, LLC | 0.00% | Reduce -14.8% | 35,620 | $32K |
| Renaissance Technologies | 0.00% | Add +10.3% | 24,670 | $22K |
| State Street Corp. | 0.00% | No change | 15,322 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.5% | 1,102 | $981 |
| Bank of America Corp. | 0.00% | Add +0.6% | 982 | $873 |
| Raymond James Financial Inc. | 0.00% | New | 320 | $285 |
| Osaic Holdings, Inc. | 0.00% | No change | 210 | $185 |
| Costello Asset Management, INC | 0.00% | No change | 200 | $178 |
| Morgan Stanley | 0.00% | No change | 144 | $128 |
| UBS Group AG | 0.00% | Reduce -93.3% | 110 | $98 |
| Wells Fargo & Company | 0.00% | No change | 102 | $91 |
| Jones Financial Companies LLLP | 0.00% | New | 60 | $55 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 61 | $54 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 60 | $53 |
| Vision Financial Markets LLC | 0.00% | No change | 40 | $36 |
| Rothschild Investment LLC | 0.00% | No change | 14 | $12 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -15.4% | 11 | $10 |
| Farther Finance Advisors, LLC | 0.00% | No change | 5 | $4 |
| FMR LLC | 0.00% | Add +100.0% | 2 | $2 |
| MAI Capital Management | 0.00% | New | 2 | $2 |
"% of holder's portfolio" is MTNB's weight in each manager's 13F, not the share of Matinas Biopharma Holdings I the manager owns.